Clinical Trial Update: Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of SAL-0951 for renal anemia in patients receiving peritoneal dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• SAL-0951

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Anemia | Phase 3 | Status: COMPLETED